[{"NetIncomeLoss_1_Q1_USD":-32860000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":-5121000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":28920000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":69300000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-12124000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1571323.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-3475000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3053000.0,"AssetsCurrent_0_Q1_USD":109066000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":89300210.0,"OtherNoncashIncomeExpense_1_Q1_USD":-94000.0,"DueToRelatedPartiesNoncurrent_0_Q1_USD":193700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":12889100.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":2190000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3127000.0,"CommonStockSharesIssued_0_Q1_shares":90137012.0,"Assets_0_Q1_USD":126682000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-3475000.0,"ShareBasedCompensation_1_Q1_USD":7812000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":10790000.0,"InterestExpenseOther_1_Q1_USD":0.0,"ContractWithCustomerLiability_0_Q1_USD":16667000.0,"InterestExpenseRelatedParty_1_Q1_USD":2184000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":22828000.0,"MarketableSecuritiesCurrent_0_Q1_USD":14970000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2210000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":44186000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":16725000.0,"AssetsFairValueDisclosure_0_Q1_USD":69987000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-140000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":3569000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":672000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"CommonStockValue_0_Q1_USD":2000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":0.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_1_Q1_USD":0.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":82190000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":3000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-36335000.0,"OtherAssetsNoncurrent_0_Q1_USD":4373000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":84726000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":10571000.0,"Liabilities_0_Q1_USD":261292000.0,"OperatingLeaseLiability_0_Q1_USD":12156000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-855000.0,"ProceedsFromRelatedPartyDebt_1_Q1_USD":80000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.0209,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-23333000.0,"DeferredRevenue_0_Q1_USD":16667000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":4569000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":8082000.0,"CommonStockSharesOutstanding_0_Q1_shares":90137012.0,"RestrictedCashNoncurrent_0_Q1_USD":1374000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":14973000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":33333000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":8648078.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-3475000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-32188000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7812000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-61984000.0,"LeaseCost_1_Q1_USD":819000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":3028000.0,"AccountsPayableCurrent_0_Q1_USD":5388000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":86100000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9370000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2190000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2536000.0,"AdditionalPaidInCapital_0_Q1_USD":694383000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":302076.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"OperatingLeasePayments_1_Q1_USD":729000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2453000.0,"LiabilitiesCurrent_0_Q1_USD":52584000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-823874000.0,"VariableLeaseCost_1_Q1_USD":90000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":2409000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1101000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-9946000.0,"CommonStockSharesAuthorized_0_Q1_shares":564111242.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":33333000.0,"OperatingIncomeLoss_1_Q1_USD":-33681000.0,"ForeignCurrencyTransactionGainBeforeTax_1_Q1_USD":3569000.0,"InvestmentIncomeInterest_1_Q1_USD":108000.0,"OperatingLeaseCost_1_Q1_USD":729000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":126682000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3236128.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":6994000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":344471.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1585000.0,"OperatingExpenses_1_Q1_USD":67014000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.37,"OtherLiabilitiesNoncurrent_0_Q1_USD":4437000.0,"StockholdersEquity_0_Q1_USD":-134610000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":151000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":8648078.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":7812000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":763000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20200630","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200811"}]